Adamis Pharmaceuticals Corporation (ADMP) has a market capitalization of $7.25M and trades at $0.78. The 52-week range is 0.4505-21.699999.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-12.24, annual revenue of $4.76M.
The stock has a beta of 1.28, operates in the Healthcare sector.
